MEDICA 2025
Messe Düsseldorf
top of page
Pioneering
Ultrasound AI
The Future of Ultrasound Imaging is Here
At AmCad BioMed, we are pioneering the integration of artificial intelligence (AI) into ultrasound imaging, revolutionizing the way healthcare professionals diagnose and treat patients. Our ultrasound AI software solutions are designed to streamline workflows, enhance diagnostic accuracy, and elevate the overall quality of patient care.
Clarity in Diagnosis
Ultrasound AI
AmCad BioMed delivered the world’s first ultrasound AI solution, advancing accuracy in early detection.
1st
30% Indeterminate Thyroid Nodules
Up to 30% of thyroid nodules are indeterminate cases by conventional ultrasound interpretation.
Source: American Thyroid Association, Mayo Clinic
80% Undiagnosed OSA
Up to 80% of OSA cases go undiagnosed, delaying treatment and raising health risks.
Source: American Academy of Sleep Medicine, Centers for Disease Control and Prevention
50% Missed in Dense Breasts
Up to 50% of breast cancers are missed in women with dense breast tissue using standard imaging alone.
Source: American Cancer Society, National Cancer Institute, Breast Cancer Surveillance Consortium
Our Solutions
News & Events
Knowledge
bottom of page